|
gptkbp:instance_of
|
gptkb:pharmaceuticals
|
|
gptkbp:activities
|
broad-spectrum
|
|
gptkbp:atccode
|
J01 MA14
|
|
gptkbp:available_on
|
gptkb:tablet
injection
|
|
gptkbp:brand
|
gptkb:Avelox
|
|
gptkbp:casnumber
|
118716-47-4
|
|
gptkbp:category
|
gptkb:C
|
|
gptkbp:chemical_formula
|
C21 H24 FN3 O4
|
|
gptkbp:class
|
gptkb:fluoroquinolone
|
|
gptkbp:clinical_trial
|
Phase IV
Phase III
|
|
gptkbp:contraindication
|
gptkb:myasthenia_gravis
tendon disorders
|
|
gptkbp:counseling_services
|
avoid sun exposure
stay hydrated
do not take with dairy products
complete full course
report tendon pain
|
|
gptkbp:dosage_form
|
250 mg IV once daily
400 mg once daily
|
|
gptkbp:effective_date
|
gptkb:1999
|
|
gptkbp:excretion
|
urine
|
|
gptkbp:formulation
|
oral tablet
IV solution
|
|
gptkbp:healthcare
|
yes
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Avelox
|
|
gptkbp:ingredients
|
gptkb:moxifloxacin
|
|
gptkbp:interacts_with
|
gptkb:theophylline
gptkb:warfarin
NSAIDs
antacids
diuretics
|
|
gptkbp:lifespan
|
12 hours
|
|
gptkbp:manufacturer
|
gptkb:Bayer_AG
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:name
|
Essential Medicines
|
|
gptkbp:packaging
|
blister pack
vial
|
|
gptkbp:route_of_administration
|
oral
intravenous
|
|
gptkbp:side_effect
|
dizziness
headache
nausea
diarrhea
insomnia
liver enzyme elevation
hypersensitivity
photosensitivity
tendon rupture
QT prolongation
|
|
gptkbp:storage
|
room temperature
|
|
gptkbp:used_for
|
bacterial infections
|
|
gptkbp:bfsParent
|
gptkb:Bayer_Health_Care
|
|
gptkbp:bfsLayer
|
6
|